Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-Specific Cerebral Vessel Templates Across the Lifespan of Healthy Adults.

Scientific data·2026
Same author

Evolutionary implications of <i>NOTCH2NLC</i> mutations: brain structural changes in neuronal intranuclear inclusion disease revealed by comprehensive morphometry.

Brain communications·2026
Same author

Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis.

The journal of headache and pain·2026
Same author

Population Pharmacokinetic Modeling Study of Glibenclamide in Chinese Healthy Volunteers.

European journal of drug metabolism and pharmacokinetics·2026
Same author

Transient cerebellum-related network disruption characterizes postoperative cognitive changes after dominant hemisphere subtemporal meningioma resection.

Acta neurochirurgica·2026
Same author

A multi-modal foundation model for brain disease diagnosis and medical imaging.

Patterns (New York, N.Y.)·2026
Same journal

Brain Aging in Specific Phobia: An ENIGMA-Anxiety Mega-Analysis.

Human brain mapping·2026
Same journal

Talking to the Brain: Using Large Language Models as Proxies to Model Brain Semantic Features.

Human brain mapping·2026
Same journal

Emotional Context Modulates the Response to Somatosensory Stimuli Within 20 milliseconds.

Human brain mapping·2026
Same journal

GABAergic Modulation of Brain Function During Prosaccade and Antisaccade Eye Movements: Evidence From Ultra-High-Field fMRI.

Human brain mapping·2026
Same journal

Injury Severity Influences Long-Term Cognitive Control in Pediatric "Mild" Traumatic Brain Injury.

Human brain mapping·2026
Same journal

Early Adulthood Signatures of Motherhood in Brain Aging.

Human brain mapping·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.3K

Thalamic Network Controllability Predicts Cognitive Impairment in Multiple Sclerosis.

Yuping Yang1, Anna Woollams1, Ilona Lipp2

  • 1Division of Psychology, Communication and Human Neurosciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Human Brain Mapping
|July 10, 2025
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) impairs the thalamus's ability to control brain network activity transitions, impacting cognitive function. This thalamic dysfunction is a key factor in cognitive impairment in MS patients.

Keywords:
cognitive impairmentmultiple sclerosisnetwork controllabilityresting‐state fMRIsubcortical networkthalamus

More Related Videos

Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation
09:52

Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation

Published on: February 23, 2020

9.3K
Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
14:47

Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning

Published on: April 21, 2023

3.0K

Related Experiment Videos

Last Updated: Jun 8, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.3K
Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation
09:52

Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation

Published on: February 23, 2020

9.3K
Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
14:47

Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning

Published on: April 21, 2023

3.0K

Area of Science:

  • Neuroscience
  • Cognitive Science
  • Medical Imaging

Background:

  • Cognitive impairment is common in multiple sclerosis (MS).
  • MS damages specific brain regions like the thalamus.
  • Altered brain network activity transitions are linked to cognitive deficits in MS.

Purpose of the Study:

  • To investigate how MS affects brain region controllability in driving network activity transitions.
  • To examine the relationship between altered controllability and cognitive impairment in MS patients.
  • To assess the thalamus's role in MS-related cognitive deficits.

Main Methods:

  • Resting-state functional MRI and neuropsychological data from MS patients and healthy controls.
  • Functional network controllability analysis to quantify regional influence on brain state transitions.
  • Replication of findings in an independent dataset.

Main Results:

  • MS is associated with altered controllability in the subcortical network, especially the thalamus.
  • Cognitively impaired MS patients showed reduced thalamic control over brain transitions.
  • Thalamic network controllability effectively distinguished MS from controls and predicted cognitive status.

Conclusions:

  • The thalamus in MS exhibits reduced capability to facilitate brain activity transitions crucial for cognitive functions.
  • Thalamic damage in MS disrupts network dynamics, potentially explaining cognitive impairment.
  • Altered thalamic controllability serves as a potential biomarker for cognitive deficits in MS.